463PReal-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study.

Autor:	O'Connor, J M1 (AUTHOR), Ducreux, M2 (AUTHOR), Petersen, L N3 (AUTHOR), Öhler, L4 (AUTHOR), Bergamo, F5 (AUTHOR), Metges, J-P6 (AUTHOR), Groot, J W de7 (AUTHOR), Wang, J-Y8 (AUTHOR), Paredes, B García9 (AUTHOR), Dochy, E10 (AUTHOR)
Zdroj:	Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu